Kakali Hossain
About Kakali Hossain
Kakali Hossain is a Clinical Research Associate with extensive experience in managing clinical research protocols across various therapeutic areas. She has worked with notable organizations such as Aimmune Therapeutics and Genentech, contributing to significant milestones in clinical trials and regulatory processes.
Work at Aimmune Therapeutics
Kakali Hossain has been employed at Aimmune Therapeutics since 2019 as a Clinical Research Associate. In this role, she supports a global study and collaborates on regulatory processes in both the US and Europe. Prior to her current position, she worked as a Senior Clinical Trial Assistant from 2017 to 2019 and as a Clinical Trial Assistant for three months in 2017, both based in Brisbane, CA. During her tenure, she contributed to the successful integration of Aimmune Therapeutics into Nestle following its acquisition in October 2020. Hossain also played a key role in the initial FDA approval of Palforzia, which marked a significant milestone for the company.
Education and Expertise
Kakali Hossain holds a Bachelor of Medicine and Bachelor of Surgery from Mymensingh Medical College in Bangladesh. She furthered her education at the University of California, Santa Cruz, where she achieved a specialization in Clinical Trial Design and Management. Hossain possesses extensive knowledge of FDA regulations and ICH/GCP, which are essential for ensuring compliance in clinical trials. Her expertise spans multiple therapeutic areas, including Immunology, Oncology, Ophthalmology, Cardiology, Neurology, Gastroenterology, and Hepatology.
Background in Clinical Research
Kakali Hossain has a robust background in clinical research, having worked in various capacities since 2010. She served as a Clinical Research Coordinator at Stanford University Hospital in the Department of Gastroenterology and Hepatology for five months in 2010. Following this, she worked at West Coast Research LLC as a Clinical Research Coordinator for six years until 2016. Hossain also held a position as a Clinical Trial Associate Consultant at Genentech for four months in 2016 and worked at Acerta Pharma B.V. as a Clinical Trial Assistant for five months in 2017.
Achievements in Clinical Trials
Throughout her career, Kakali Hossain has made significant contributions to clinical trials. Notably, she played a key role in the initial FDA approval of Palforzia, which was a milestone achievement for Aimmune Therapeutics. Her extensive experience managing clinical research protocols across various therapeutic areas has positioned her as a knowledgeable professional in the field. Hossain's work has involved supporting global studies and collaborating on regulatory processes, enhancing the efficiency and compliance of clinical trials.